T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

doi:10.1084/jem.151.1.69

This Article

	Full Text (PDF, 1722K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Berendt, M. J.
	Articles by North, R. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Berendt, M. J.
	Articles by North, R. J.


Social Bookmarking

	What's this?

ARTICLES

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

MJ Berendt and RJ North

The results of this paper are consistent with the hypothesis that progressive growth of the Meth A fibrosarcoma evokes the generation of a T-cell-mediated mechanism of immunosuppression that prevents this highly immunogenic tumor from being rejected by its immunocompetent host. It was shown that it is possible to cause the regression of large, established Meth A tumors by intravenous infusion of tumor- sensitized T cells from immune donors, but only if the tumors are growing in T-cell-deficient recipients. It was also shown that the adoptive T-cell-mediated regression of tumors in such recipients can be prevented by prior infusion of splenic T cells from T-cell-intact, tumor-bearing donors. The results leave little doubt that the presence of suppressor T cells in T-cell-intact, tumor-bearing mice is responsible for the loss of an earlier generated state of concomitant immunity, and for the inability of intravenously infused, sensitized T cells to cause tumor regression. Because the presence of suppressor T cells generated in response to the Meth A did not suppress the capacity of Meth A-bearing mice to generate and express immunity against a tumor allograft, it is obvious that they were not in a state of generalized immunosuppression.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Mirmonsef, P., Tan, G., Zhou, G., Morino, T., Noonan, K., Borrello, I., Levitsky, H. I. (2008). Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation. Blood 111: 2112-2121 [Abstract] [Full Text]
Paulos, C. M., Kaiser, A., Wrzesinski, C., Hinrichs, C. S., Cassard, L., Boni, A., Muranski, P., Sanchez-Perez, L., Palmer, D. C., Yu, Z., Antony, P. A., Gattinoni, L., Rosenberg, S. A., Restifo, N. P. (2007). Toll-like Receptors in Tumor Immunotherapy. Clin. Cancer Res. 13: 5280-5289 [Abstract] [Full Text]
Lizee, G., Radvanyi, L. G., Overwijk, W. W., Hwu, P. (2006). Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms.. Clin. Cancer Res. 12: 4794-4803 [Abstract] [Full Text]
Beyer, M., Schultze, J. L. (2006). Regulatory T cells in cancer. Blood 108: 804-811 [Abstract] [Full Text]
Chattopadhyay, S., Mehrotra, S., Chhabra, A., Hegde, U., Mukherji, B., Chakraborty, N. G. (2006). Effect of CD4+CD25+ and CD4+CD25- T Regulatory Cells on the Generation of Cytolytic T Cell Response to a Self but Human Tumor-Associated Epitope In Vitro. J. Immunol. 176: 984-990 [Abstract] [Full Text]
Zhou, G., Drake, C. G., Levitsky, H. I. (2006). Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107: 628-636 [Abstract] [Full Text]
Liu, K., Idoyaga, J., Charalambous, A., Fujii, S.-i., Bonito, A., Mordoh, J., Wainstok, R., Bai, X.-F., Liu, Y., Steinman, R. M. (2005). Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells. JEM 202: 1507-1516 [Abstract] [Full Text]
Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., Fu, Y.-X. (2005). Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. JEM 201: 779-791 [Abstract] [Full Text]
Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C.-C., Klebanoff, C. A., Overwijk, W. W., Rosenberg, S. A., Restifo, N. P. (2005). CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells. J. Immunol. 174: 2591-2601 [Abstract] [Full Text]
Turk, M. J., Guevara-Patino, J. A., Rizzuto, G. A., Engelhorn, M. E., Houghton, A. N. (2004). Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells. JEM 200: 771-782 [Abstract] [Full Text]
Danna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A., Ostrand-Rosenberg, S. (2004). Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease. Cancer Res. 64: 2205-2211 [Abstract] [Full Text]
Bell, J. (2003). Developments at The JEM. JEM 198: 1131-1132 [Full Text]
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., Linehan, D. C. (2002). Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma. J. Immunol. 169: 2756-2761 [Abstract] [Full Text]
Eberlein, T. J., Schoof, D. D., Jung, S.-E., Davidson, D., Gramolini, B., McGrath, K., Massaro, A., Wilson, R. E. (1988). A New Regimen of Interleukin 2 and Lymphokine-Activated Killer Cells: Efficacy Without Significant Toxicity. Arch Intern Med 148: 2571-2576 [Abstract]
Kim, B., Warnaka, P., Iverson, M., Imbembo, A. L. (1987). Immunotherapy of Pulmonary Metastases Using Monoclonal Antibody to T-Cell Suppressor Factor and Interleukin 2. Arch Surg 122: 1455-1459 [Abstract]
Rosenberg, S., Spiess, P, Lafreniere, R (1986). A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318-1321 [Abstract]
Fisher, M., Kripke, M. (1982). Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216: 1133-1134 [Abstract]